Louie E Ross
Overview
Explore the profile of Louie E Ross including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Carpenter W, Howard D, Taylor Y, Ross L, Wobker S, Godley P
Cancer Causes Control
. 2010 Mar;
21(7):1071-80.
PMID: 20333462
Objectives: This study examined PSA screening interval of black and white men aged 65 or older and its association with prostate cancer stage at diagnosis. Methods: SEER-Medicare data were examined...
12.
Ross L, Meade S, Powe B, Howard D
J Natl Black Nurses Assoc
. 2009 Aug;
20(1):52-8.
PMID: 19691184
African-American men experience greater incidence and mortality from prostate cancer compared to White men as well as men from other groups. Few studies have examined prostate-specific antigen (PSA) test and...
13.
Ross L, Powe B, Taylor Y, Howard D
Am J Mens Health
. 2009 May;
2(2):156-64.
PMID: 19477779
Prostate cancer is the second leading cancer killer in men. Men in general and African American men in particular face crucial decisions regarding prostate cancer screening and perhaps treatment for...
14.
Ross L, Taylor Y, Richardson L, Howard D
J Natl Med Assoc
. 2009 Apr;
101(4):316-24.
PMID: 19397221
Background: Studies have examined prostate-specific antigen (PSA) test and digital rectal examination (DRE) use among men; however, few have examined use of these procedures together over time. This study examined...
15.
Howard D, Taylor Y, Ross L
J Natl Med Assoc
. 2008 Oct;
100(10):1146-52.
PMID: 18942275
Background: There are limited population-based studies of benign prostate hyperplasia (BPH) and lower urinary tract symptoms (LUTS) in men, and most studies examined to date have been restricted to predominately...
16.
Ross L, Hall I, Fairley T, Taylor Y, Howard D
J Altern Complement Med
. 2008 Oct;
14(8):931-8.
PMID: 18925865
Objectives: At least 10.8 million living Americans have been diagnosed with cancer, and about 1.5 million new cancer cases are expected to be diagnosed in 2008. The purpose of this...
17.
Ross L, Berkowitz Z, Ekwueme D
Cancer Epidemiol Biomarkers Prev
. 2008 Mar;
17(3):636-44.
PMID: 18349281
Background: Although evidence that prostate cancer deaths are reduced by screening for elevated prostate-specific antigen (PSA) concentration coupled with early diagnosis and treatment is insufficient to advocate routine screening for...
18.
Ross L, Richardson L, Berkowitz Z
J Natl Med Assoc
. 2006 Nov;
98(11):1823-9.
PMID: 17128693
Many medical and professional organizations agree that men should discuss the advantages and disadvantages of testing for prostate-specific antigen (PSA) with their physicians before undergoing testing. In the 2000 National...
19.
Stroud L, Ross L, Rose S
J Natl Med Assoc
. 2006 Oct;
98(10):1637-43.
PMID: 17052055
Background: Clinical guidelines for using the prostate-specific antigen (PSA) test as a population-based tool vary. This study qualitatively explores the prostate cancer screening practices of African-American primary care physicians. Methods:...
20.
Ross L, Stroud L, Rose S, Jorgensen C
J Natl Med Assoc
. 2006 Aug;
98(8):1296-9.
PMID: 16916127
African-American men have a greater burden from prostate cancer than do white men and men of other races/ethnicities in the United States. To date, there have been no studies of...